NADK

NAD kinase

Basic information

Region (hg38): 1:1751232-1780457

Links

ENSG00000008130NCBI:65220OMIM:611616HGNC:29831Uniprot:O95544AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the NADK gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the NADK gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
5
clinvar
5
missense
39
clinvar
1
clinvar
3
clinvar
43
nonsense
0
start loss
0
frameshift
0
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 39 6 4

Variants in NADK

This is a list of pathogenic ClinVar variants found in the NADK region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-1752908-C-CCCT not specified Benign (Dec 12, 2023)2672290
1-1752941-T-C not specified Uncertain significance (Jul 19, 2023)2612496
1-1752960-C-T not specified Uncertain significance (Apr 18, 2023)2521759
1-1752977-T-C not specified Uncertain significance (Jan 26, 2022)2273100
1-1753014-G-A not specified Uncertain significance (Mar 04, 2024)3173102
1-1753025-G-A not specified Uncertain significance (May 16, 2023)2546776
1-1754135-G-A Likely benign (Aug 01, 2018)762412
1-1754137-T-G not specified Uncertain significance (Jul 06, 2021)2382937
1-1754149-T-C not specified Uncertain significance (Dec 27, 2023)2377149
1-1754175-G-A not specified Uncertain significance (Aug 20, 2024)3402503
1-1754347-A-G not specified Uncertain significance (Jan 26, 2022)2402886
1-1754353-G-A not specified Uncertain significance (Jan 23, 2024)3173085
1-1754369-C-T Likely benign (Apr 01, 2022)2638060
1-1754575-A-G not specified Likely benign (Feb 28, 2025)3877510
1-1754638-C-T not specified Uncertain significance (Aug 02, 2023)2615196
1-1756298-C-T not specified Uncertain significance (Feb 07, 2025)3877507
1-1756508-C-T not specified Uncertain significance (Dec 28, 2023)3173151
1-1756523-T-C not specified Uncertain significance (Dec 23, 2024)3877508
1-1756560-T-C not specified Uncertain significance (Aug 14, 2024)3402500
1-1756620-G-A not specified Uncertain significance (Apr 22, 2022)2284660
1-1756643-G-A not specified Uncertain significance (May 20, 2024)3298362
1-1756656-T-A not specified Uncertain significance (Jan 23, 2024)3173147
1-1757120-G-A not specified Uncertain significance (Aug 05, 2023)2595213
1-1757121-G-C not specified Uncertain significance (Aug 11, 2022)2356976
1-1757129-C-T not specified Uncertain significance (Aug 05, 2024)3402502

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
NADKprotein_codingprotein_codingENST00000344463 1329226
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.13e-100.7551257150331257480.000131
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.882773800.7290.00002453787
Missense in Polyphen3990.2080.43234820
Synonymous0.1261671690.9880.00001271196
Loss of Function1.582029.20.6840.00000156305

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002650.000265
Ashkenazi Jewish0.000.00
East Asian0.0004360.000435
Finnish0.000.00
European (Non-Finnish)0.0001270.000123
Middle Eastern0.0004360.000435
South Asian0.00006620.0000653
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Pathway
Nicotinate and nicotinamide metabolism - Homo sapiens (human);Nicotinate and Nicotinamide Metabolism;NAD+ metabolism;Vitamin B3 (nicotinate and nicotinamide) metabolism;Metabolism;Nicotinate Nicotinamide metabolism;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;NAD phosphorylation and dephosphorylation (Consensus)

Recessive Scores

pRec
0.186

Intolerance Scores

loftool
0.501
rvis_EVS
-0.11
rvis_percentile_EVS
45.36

Haploinsufficiency Scores

pHI
0.153
hipred
N
hipred_score
0.446
ghis
0.587

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
S
essential_gene_gene_trap
K
gene_indispensability_pred
E
gene_indispensability_score
0.982

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Nadk
Phenotype

Gene ontology

Biological process
NADP biosynthetic process;phosphorylation;NAD metabolic process;positive regulation of insulin secretion involved in cellular response to glucose stimulus;ATP metabolic process
Cellular component
cytosol
Molecular function
NAD+ kinase activity;protein binding;ATP binding;metal ion binding